TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sanofi-Aventis Norge AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
817,667
|
741,575
|
729,437 |
| Financial expenses |
4,587
|
1,287
|
1,384 |
| Earnings before taxes |
47,251
|
41,459
|
62,957 |
| Total assets |
348,105
|
347,336
|
421,617 |
| Current assets |
344,946
|
344,814
|
418,922 |
| Current liabilities |
333,676
|
342,130
|
367,758 |
| Equity capital |
14,429
|
5,205
|
53,859 |
| - share capital |
1,765
|
1,797
|
1,924 |
| Employees (average) | 64 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.1%
|
1.5%
|
12.8% |
| Turnover per employee | 12,776 | ||
| Profit as a percentage of turnover |
5.8%
|
5.6%
|
8.6% |
| Return on assets (ROA) |
14.9%
|
12.3%
|
15.3% |
| Current ratio |
103.4%
|
100.8%
|
113.9% |
| Return on equity (ROE) |
327.5%
|
796.5%
|
116.9% |
| Change turnover |
89,226
|
60,467
|
-47,189 |
| Change turnover % |
12%
|
9%
|
-6% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.